Skip to content

CYTK

Cytokinetics, Incorporated

Stock

$65.62−0.29 (−0.44%)Close Oct 1, 2026

Operating income (TTM)−$708M

Operating income

PeriodOperating incomeYoY
2025−$612M—
2024−$536M—
2023−$496M—
2022−$324M—
2021−$186M—
2020−$94M—
2019−$99M—
2018−$89M—
2017−$113M—
2016$19M—
2015−$37M—
2014−$15M—
2013−$34M—
2012−$40M—
2011−$48M—
2010−$50M—
2009$26M—